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PHP1
COMPLIANCE WITH DRUG TREATMENT IN
SWEDEN:AN EPIDEMIOLOGICAL STUDY
Bingefors K, Isacson D
Uppsala University, Uppsala, Sweden
OBJECTIVE: Most studies on medication compliance
originate in the medical care setting. In this study the aim
was to analyze self-reported compliance with prescription
drug treatment in a population. METHODS: Cross-
sectional survey, statistical sample, 20–84 years, in the
County of Uppland, Sweden. Those answering the ques-
tionnaire totaled 5404 (68%). A recall period of two
weeks was used for use of prescription drugs. Logistic
regression analysis was used for the multivariate analy-
ses. RESULTS: The use of prescription drugs was
reported by 2604 persons (48.2%). Of these users 63.5%
reported that they had on occasion or often forgotten to
take their medicines, 20.8% reported that they had
changed dosages on their own and 25.5% answered that
they had stopped medication on their own accord. Men
stopped taking drugs to a greater extent than women;
older persons were more likely to continue drug treatment
as prescribed. Individuals with a higher educational level
and those with a good medication knowledge reported
that they stopped taking prescription drugs to a greater
extent than others. The same pattern was seen with
respect to the changing of dosages. Further, we found that
it was less common that users of drugs for hypertension,
users of cardiovascular drugs, users of drugs for angina,
and users of antibiotics stopped taking drugs on their
own accord while it was more common that users of anal-
gesics, and users of hypnotics, anxiolytics and antide-
pressants stopped taking drugs as compared to other
users. CONCLUSION: This epidemiological study high-
lights that non-compliance is a public health problem,
that there are variations between users of different types
of drugs, and that much more research is needed on non-
medical and medical factors affecting medication compli-
ance in the population.
PHP2
THE ASSOCIATION OF PRACTICE GUIDELINES
AND OTHER FACTORS WITH HOSPITAL
LENGTH OF STAY (LOS) AND MORTALITY IN
PATIENTS WITH COMMUNITY-ACQUIRED
PNEUMONIA (CAP), HEART FAILURE (HF) AND
SEDATED INTENSIVE CARE PATIENTS
Bonnet PO1, Chaikledkaew U1, Hopeﬂ A2, Johnson KA1
1University of Southern California, Los Angeles, CA, USA;
2AmeriNet, St. Louis, MO, USA
OBJECTIVES: To investigate the association of the Joint
Commission on the Accreditation of Healthcare Organi-
zations (JCAHO) core performance measures, practice
guidelines and other factors with hospital length of stay
(LOS) and mortality in patients with community-acquired
pneumonia (CAP), heart failure (HF) or sedated intensive
care unit (ICU) patients. METHODS: Data included
2238 patients with CAP, 622 patients admitted to the ICU
and 1340 patients with HF, from 88 hospitals during a
3-month period. Data included patient demographic, hos-
pital characteristics and outcome measures. Univariate
and multivariate analyses such as ordinary least square
(OLS) and logistic regression were performed. RESULTS:
Based on the results from OLS regression analysis, older
age is signiﬁcantly associated with longer LOS (p <
0.0001) for all conditions. Also, patient admission to hos-
pitals with a care plan (p < 0.0120) and the number of
patient co-existing illnesses (p < 0.0016) were signiﬁ-
cantly related to an increase in LOS. Patients receiving
care according to practice guidelines have a signiﬁcantly
shorter LOS. Logistic regression results show that older
age (odds ratio, OR = 1.029, p < 0.0001) and male gender
(OR = 0.701, p < 0.0036) were signiﬁcantly associated
with higher mortality. Compliance with practice guide-
lines had a signiﬁcant impact on decreasing mortality
regardless of conditions. CONCLUSIONS: Compliance
with practice guidelines may reduce LOS and mortality,
which suggests improved patient outcomes and decreased
healthcare costs.
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OBJECTIVES: Compliance with heart failure treatment
guidelines may improve quality of care and reduce health-
care utilization and costs. For accreditation purposes,
hospitals are required by the Joint Commission on the
Accreditation of Healthcare Organizations (JCAHO) to
measure performance for treatment of patients with heart
failure. The purpose of this study is to determine the effect
of hospital compliance with JCAHO performance 
measures and published guidelines on outcomes of
patients with heart failure (HF). METHODS: Thirty hos-
pitals submitted data on 1340 patients admitted with HF
between January 2, 2002 and March 30, 2002. The data
included patient demographics, HF severity, co-existing
illnesses, and type of medication therapy during hospi-
talization and at discharge. Univariate and multivariate
analyses such as ordinary least square (OLS) regression,
logistic regression, and Cox regression analyses were
applied. RESULTS: Current tobacco use and co-existing
illnesses such as cardiomyopathy and chronic renal
disease were signiﬁcantly associated with longer hospital
length of stay (LOS). Moreover, patients admitted to com-
munity hospitals had a lower inpatient mortality rate.
Patients receiving discharge instructions regarding follow-
up appointment and weight monitoring had signiﬁcantly
lower hospital LOS and mortality. Overall, patients
receiving treatment according to published guidelines 
had lower hospital LOS and inpatient mortality rate.
However, receiving treatment in hospitals with a care plan
for HF had no signiﬁcant impact on LOS or mortality.
CONCLUSIONS: Hospital compliance with JCAHO per-
formance measures and published guidelines is associated
with a signiﬁcant reduction in patient LOS or inpatient
mortality. However, patients treated in hospitals with a
care plan for heart failure had no signiﬁcant change in
LOS or mortality.
PHP4
BIAS IN CATEGORICAL MEDICATION
COMPLIANCE ASSESSMENT
Cramer JA
Yale University School of Medicine, West Haven, CT, USA
OBJECTIVE: To demonstrate the bias inherent in using
categorical data for medication compliance assessments.
METHODS: Two datasets from studies in which patients
used electronic monitors (MEMS, AARDEX, Union City,
CA) to record long-term daily dosing were used for analy-
ses comparing categorical compliance (>50%, >60%,
>70%, >80%, >90%). Study A compared an intervention
to improve medication compliance with a usual care
control group in a study of Medication Usage Skills for
Effectiveness Program (MUSE-P) (Cramer, J Nerv Ment
Dis, 1999). Study B assessed compliance as a covariate 
to medication efﬁcacy (Krystal, Cramer, NEJM, 2001).
RESULTS: In Study A, analysis by categories of >50%,
>60%, >70%, >80%, and >90% compliance rates 
provided different results for the comparisons between
the intervention and control groups. The proportions of
Intervention and Control group patients who would have
been considered compliant were 90–87%, 85–71%,
77–61%, 64–34%, 54–24%, respectively by category.
Differences between the intervention and control groups
increased with higher standards of compliance (ratios
1.06, 1.22, 1.30, 1.92, 2.33). In Study B, decreasing pro-
portions of patients met criteria for compliance categories
(56%, 50%, 44%, 35%, 26%, respectively). Changing
categories affected regression models with the primary
outcome. CONCLUSIONS: This exercise demonstrated
the biases that occur when compliance is calculated by
category because of lack of information to support selec-
tion of a category designating appropriate compliance.
Information that would deﬁne a category below which 
a medication is ineffective is available for very few 
medications. Without such information, selection of a
category as a determinant of medication compliance is
inappropriate. This problem was removed by using 
continuous compliance data.
PHP5
CORRELATIONS BETWEEN A STAGE OF
CHANGE MEASURE AND FOUR VALIDATED
MEASURES OF MEDICATION COMPLIANCE
Cook CL, Perri III M
University of Georgia, Athens, GA, USA
OBJECTIVES: The literature contains a plethora of 
articles on medication compliance research, however, no
“gold standard” in the measurement of compliance has
been established. The Stage of Change (SOC) construct
measure from the Transtheoretical Model of behavioral
change has recently been validated in medication compli-
ance. The objective of this study is to compare the SOC
measure against Four other validated compliance mea-
sures in patients being treated for diabetes, hypertension,
hypercholesterolemia, hypothyroidism, and hormone
replace therapy. METHODS: A total of 171 male and
female patients in ﬁve primary care physician ofﬁces in
the state of Georgia, USA, completed a face-to-face ques-
tionnaire consisting of the SOC measure, the Medication
Adherence Scale, the Medication Outcomes Survey
(MOS) compliance question, the Brief Medication 
Compliance Questionnaire (BMQ) and sociodemo-
graphic information. Pharmacy reﬁll records (RR) were
collected as the ﬁfth compliance measure. RESULTS:
Pearson correlations ranged from a low of 0.09 between
RR and BMQ to a high of 0.79 between SOC and MOS.
All other correlations ranged between 0.20 and 0.49. All
correlations proved signiﬁcantly different than zero (p <
0.05) with the exception of the RR and BMQ correlation.
CONCLUSIONS: The majority of correlations between
validated measures of compliance ranged from weak to
moderate in strength. Therefore the results of this study
show selection of a useful compliance measure is difﬁcult.
The study ﬁndings emphasize that assessing medication-
taking behavior of patients and comparing the results of
different compliance studies is problematic. The develop-
